sizofiran has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleem, E; Baddour, N; Daba, A; El-Saadani, M; Mansour, A | 1 |
| Arika, T; Iwano, K; Kikuchi, M; Mitani, M | 1 |
| Hamada, F; Hirota, S; Inomata, T; Maeda, T; Morita, M; Morita, S; Ogawa, Y; Ohara, S; Sawada, A; Yoshida, S | 1 |
3 other study(ies) available for sizofiran and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Proliferation; Female; Immunohistochemistry; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Schizophyllum; Sizofiran; Survival Analysis; Tamoxifen | 2012 |
[Experimental study on immunochemotherapy using schizophyllan].
Topics: Adjuvants, Immunologic; Animals; Glycosaminoglycans; Macrophage Activation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Neoplasms, Experimental; Plasmacytoma; Sizofiran; T-Lymphocytes; Zinostatin | 1982 |
[Combination therapy of radiation and SPG (schizophyllan) in the treatment of MM46 tumor transplanted in C3H/He mice].
Topics: Animals; Combined Modality Therapy; Glycosaminoglycans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Sizofiran; T-Lymphocytes | 1986 |